X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule
X4 Pharmaceuticals announced that effective September 30, 2026, it issued inducement awards to new employees under Nasdaq Listing Rule 5635(c)(4).
X4 Pharmaceuticals announced that effective September 30, 2026, it issued inducement awards to new employees under Nasdaq Listing Rule 5635(c)(4).